Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07311941) titled 'Rapid Escalation of LipiD Lowering Therapy to Reduce RecUrrent Cardiovascular Event' on Dec. 17, 2025.

Study Type: Observational

Primary Sponsor: Chinese University of Hong Kong

Condition: Hyperlipidemia Cardio Vascular Disease

Recruitment Status: Recruiting

Date of First Enrollment: December 30, 2024

Target Sample Size: 1000

Countries of Recruitment: Hong Kong

To know more, visit https://clinicaltrials.gov/study/NCT07311941

Published by HT Digital Content Services with permission from Health Daily Digest....